Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_assertion type Assertion NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_head.
- NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_assertion description "[Epidermal growth factor receptor inhibitor therapy is now approved for treatment of metastatic colorectal carcinomas (CRC) in patients with tumors lacking KRAS mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_provenance.
- NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_assertion evidence source_evidence_literature NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_provenance.
- NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_assertion SIO_000772 21122130 NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_provenance.
- NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_assertion wasDerivedFrom befree-2016 NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_provenance.
- NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_assertion wasGeneratedBy ECO_0000203 NP856123.RAZIk2mEpbYKh1tIUSzCX5pnGN-RKMh6OWZbpuJbBIhqw130_provenance.